Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
125.17
+2.59 (2.11%)
At close: Jul 1, 2026, 4:00 PM EDT
127.00
+1.83 (1.46%)
After-hours: Jul 1, 2026, 6:28 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $8.05 billion as of July 1, 2026. Its market cap has increased by 137.61% in one year.
Market Cap
8.05B
Enterprise Value
7.44B
1-Year Change
137.61%
Ranking
Category
Stock Price
$125.17
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $8.05B, an increase of 4,593.79%. That is a compound annual growth rate of 47.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 8.05B | 47.43% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 9.50B |
| Kymera Therapeutics | 9.40B |
| Halozyme Therapeutics | 9.13B |
| Praxis Precision Medicines | 8.91B |
| Vaxcyte | 8.10B |
| Immunovant | 7.83B |
| Spyre Therapeutics | 7.72B |
| TG Therapeutics | 7.59B |